SurVaxM for newly diagnosed glioblastoma: an interview with Manmeet Ahluwalia

Written by Sharon Salt (Editor)

Manmeet Ahluwalia, MD, is Director of the Brain Metastases Research Program at Cleveland Clinic (OH, USA). He is also the Dean and Diane Miller Family Endowed Chair in Neuro-Oncology at the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center and a Professor in the Department of Medicine at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University (OH, USA). Manmeet’s research focuses on the development of new therapies for people with brain tumors and brain metastases. Currently, he leads several clinical trials involving immune therapy and new targeted therapies, as well as treatments targeting blood vessels and cancer...

To view the full article, please register now for access

It's completely free